Literature DB >> 16555931

Single nucleotide polymorphisms (SNPs) at CDH1 promoter region in familial gastric cancer.

A Ramos-de la Medina1, H More, H Medina-Franco, B Humar, A Gamboa, L J Ortiz, J H Donohue, P Guilford.   

Abstract

INTRODUCTION: Gastric cancer is the most frequent gastrointestinal malignancy in Mexico and the proportion of patients younger than 40 years is one of the highest reported in the world literature. Recently several families with familial diffuse gastric cancer have been identified at the National Institute of Medical Sciences and Nutrition. Germline mutations in the E-cadherin gene (CHD1) have been described that result in the development of diffuse hereditary gastric cancer in young patients.
METHODS: The complete coding sequence at exons 1 to 16 and the promoter region of CDH1 was amplified by polymerase chain reaction in peripheral blood samples of two patients with early onset familial diffuse gastric cancer.
RESULTS: No germline inactivating mutations of CHD1 were found on either patient. Single nucleotide polymorphisms -160 C->A were detected in the promoter region of CDH1 in both patients.
CONCLUSIONS: The polymorphism -160 C->A theoretically confers an increased risk of developing diffuse gastric cancer. The relatives of these patients may an increased risk of gastric cancer among other tumors. There is presently not enough evidence to consider the -160 C->A polymorphism an etiologic factor of diffuse gastric cancer in these patients since the frequency and type of genetic alterations of CDH1 are largely unknown in the Mexican population. It will be necessary to conduct epidemiologic studies in the Mexican population to determine the influence that genetic alterations have on the genesis of diffuse gastric carcinoma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16555931     DOI: 10.4321/s1130-01082006000100005

Source DB:  PubMed          Journal:  Rev Esp Enferm Dig        ISSN: 1130-0108            Impact factor:   2.086


  2 in total

Review 1.  Mutational landscape of gastric adenocarcinoma in Latin America: A genetic approach for precision medicine.

Authors:  Dennis Cerrato-Izaguirre; Yolanda I Chirino; Claudia M García-Cuellar; Miguel Santibáñez-Andrade; Diddier Prada; Angélica Hernández-Guerrero; Octavio Alonso Larraga; Javier Camacho; Yesennia Sánchez-Pérez
Journal:  Genes Dis       Date:  2021-04-24

2.  Lauren classification and individualized chemotherapy in gastric cancer.

Authors:  Junli Ma; Hong Shen; Linda Kapesa; Shan Zeng
Journal:  Oncol Lett       Date:  2016-03-16       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.